Study identifier:NIS-NDK-SER-2010/2
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A retrospective, non-interventional study to evaluate the use of Seroquel XR and Seroquel IR in the clinical practice of outpatients with schizophrenia
schizophrenia
-
No
-
All
186
Observational
18 Years - 65 Years
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Mar 2011 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
300 patients Female or male aged 18-65 years with a diagnosis of schizophrenia having received at least one dose of Seroquel XR or Seroquel IR during January – March 2010 | - |